Xu Li

13PUBLICATIONS
11CO-AUTHORS
Medical bacteriologyAllergyInfant and child healthPharmacogenomicsPollution and contamination not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Dec 15, 2025
Effectiveness and Safety of Mepolizumab in Allergic Bronchopulmonary Aspergillosis (ABPA): Real-World Experience From a Chinese Retrospective Case Series.

Xu Li, Peize Liu, Tingting Gao

|Nov 24, 2025
Safety and efficacy of stapokibart, an anti-interleukin-4 receptor α monoclonal antibody, in children aged 6-11 years with moderate-to-severe atopic dermatitis: an open-label single-arm phase Ib/IIa trial.

Mutong Zhao, Zigang Xu, Liming Wu

|Sep 29, 2025
Efficacy and Safety of Omalizumab Combined with Allergen-Specific Immunotherapy in the Treatment of Moderate-to-Severe Allergic Asthma: A Prospective Cohort Study in a Chinese Population.

Na Liu, Peng Jin, Xu Li

|Aug 27, 2025
Multi-Omics Profiling of the 42-Day Infant Gut as a Pilot Predictor of Atopic Dermatitis at One Year: A Birth Cohort Study in China.

Mutong Zhao, Xu Li, Yan Li

|Jun 06, 2025
Real-World Efficacy and Safety of Dupilumab Retreatment in Adults With Relapsed Atopic Dermatitis: A Retrospective Study From China.

Anda Zhang, Xu Li, Hong Liu

|May 29, 2025
Reconsidering 'comet sign': The overlooked possibility of herpes zoster.

Xu Li, Peng Jin, Lili Zhi

Pageof 3

Frequent Collaborators

6 joint publications

Lili Zhi

2 joint publications

Mutong Zhao

2 joint publications

Qiri Mu

2 joint publications

Peng Jin